Stockscreener 앱 받기
0.955
4.23%
-0.0422
시간 외 거래:
.96
0.005
+0.52%
전일 마감가:
$0.9972
열려 있는:
$0.99
하루 거래량:
12,049
Relative Volume:
0.18
시가총액:
$31.45M
수익:
-
순이익/손실:
$-563.30K
주가수익비율:
-0.3673
EPS:
-2.6
순현금흐름:
$-22.23M
1주 성능:
-3.97%
1개월 성능:
+0.53%
6개월 성능:
-47.81%
1년 성능:
-27.29%
1일 변동 폭
$0.95
$0.99
1주일 범위
$0.91
$1.04
52주 변동 폭
$0.91
$3.10
Promis Neurosciences Inc Stock (PMN) Company Profile
명칭
Promis Neurosciences Inc
전화
416-847-6898
주소
SUITE 200, 1920 YONGE STREET, TORONTO
PMN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| PMN | 0.955 | 31.45M | 0 | -563.30K | -22.23M | -2.60 |
| VRTX | 450.37 | 115.10B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.07B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.20B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 25.09B | 3.30B | -501.07M | 1.03B | 11.54 |
Promis Neurosciences Inc 주식(PMN)의 최신 뉴스
ProMIS Neurosciences stock hits 52-week low at $0.91 - Investing.com
ProMIS Neurosciences stock hits 52-week low at $0.91 By Investing.com - Investing.com Australia
ProMIS Neurosciences Announces Third Quarter Financial Results and Recent HighlightsOn November 14, 2024, ProMIS Neurosciences Inc. (Nasdaq: PMN) shared its financial outcomes for the third quarter ended September 30, 2024. The company provide - Defense World
ProMIS Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
GREAT POINT PARTNERS LLC Acquires Shares in ProMIS Neurosciences Inc - GuruFocus.com
ProMIS Neurosciences Inc (PMN) Quarterly 10-Q Report - Quartzy
ARMISTICE CAPITAL, LLC Acquires New Stake in ProMIS Neurosciences Inc - GuruFocus.com
ProMIS Neurosciences Inc Reports Q3 2024 GAAP EPS of $0.31, Surp - GuruFocus.com
ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights - GlobeNewswire
ProMIS Reports Positive Phase 1a Results for Alzheimer's Drug, Secures $30.3M Financing | PMN Stock News - StockTitan
ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference - GlobeNewswire
ProMIS Neurosciences (STU:23J0) PensionAndRetirementBenefit : €0.43 Mil (As of Jun. 2024) - GuruFocus.com
Biotech Shares Positive Phase I Data for Alzheimer's Treatment - Streetwise Reports
ProMIS Neurosciences Presents Positive Data from PMN310 - GlobeNewswire
ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference - StockTitan
ProMIS Neurosciences, Inc. (NASDAQ:PMN): Among The 10 Oversold Canadian Stocks to Buy Right Now - Insider Monkey
ProMIS Neurosciences stock hits 52-week low at $0.92 - Investing.com India
ProMIS Neurosciences stock hits 52-week low at $0.92 By Investing.com - Investing.com South Africa
ProMIS Neurosciences, Inc. (PMN): Analysts Are Bullish On This Undervalued Canadian Stock Now - Insider Monkey
ProMIS Neurosciences appoints new CEO Neil Warma By Investing.com - Investing.com Australia
ProMIS Neurosciences appoints new CEO Neil Warma - Investing.com
ProMIS Neurosciences Names Neil Warma Permanent CEO - TipRanks
ProMIS Neurosciences (NASDAQ:PMN) versus Rigel Pharmaceuticals (NASDAQ:RIGL) Head-To-Head Analysis - Defense World
ProMIS Neurosciences And 2 Other Stocks Under $5 Executives Are Buying - MSN
Director Madge Shafmaster Acquires 200,000 Shares of ProMIS Neur - GuruFocus.com
ProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Madge K. Shafmaster Acquires 60,000 Shares - Defense World
ProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Buys $89,600.00 in Stock - Defense World
ProMIS Neurosciences director Shafmaster purchases $255,750 in stock By Investing.com - Investing.com South Africa
ProMIS Neurosciences director Shafmaster purchases $255,750 in stock - Investing.com India
ProMIS Neurosciences (NASDAQ:PMN) versus Regulus Therapeutics (NASDAQ:RGLS) Critical Contrast - Defense World
BSE SME Popular Foundation slips on debut - Business Standard
Popular Foundations shares list at IPO price on BSE SME platform - The Economic Times
Popular Foundations makes tepid debut, shares list flat at ₹37 apiece on BSE SME platform - Upstox
How To Check Popular Foundations IPO Allotment Status - NDTV Profit
Taking a look at what insiders are doing to gauge the PureCycle Technologies Inc (PCT)’s direction - Knox Daily
Popular Foundations IPO allotment to be finalized today - IPO Watch
Prosperity Bancshares, Inc. (NYSE:PB) Shares Bought by Federated Hermes Inc. - Defense World
The Psychology of PureCycle Technologies Inc Inc. (PCT) Price Performance: Understanding Market Sentiment - The InvestChronicle
ProMIS Neurosciences to Showcase PMN310’s Ability to Target - GlobeNewswire
ProMIS unveils promising Alzheimer's antibody data at ICBN By Investing.com - Investing.com Australia
ProMIS unveils promising Alzheimer's antibody data at ICBN - Investing.com India
Pre-market Movers: TNON, FULC, SMFL, RYDE, NTGR… - RTTNews
ProMIS Neurosciences (NASDAQ:PMN) Trading Down 5% - Defense World
Promis Neurosciences Inc (PMN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
3.55%
자본화:
|
볼륨(24시간):